B
ChinaDescription
Biologics CDMO focused on antibody-based therapies, end to end: cell line development, culture and purification, analytical methods, formulation, process validation, cGMP manufacturing of drug substance and drug product in vials, syringes and cartridges, and dossier preparation. It reports single-use bioreactors from 200 to 2,000 litres.